Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nelkin

Showing results (131-140 of 150) with videos related to

Pageof 15
Sort By:
Cancer Research|October 5, 2001
BARX2 induces cadherin 6 expression and is a functional suppressor of ovarian cancer progressionG C Sellar, L Li, K P Watt, et al.
Atmosphere|July 18, 2018
The Global Precipitation Climatology Project (GPCP) Monthly Analysis (New Version 2.3) and a Review of 2017 Global PrecipitationR F Adler, M Sapiano, G J Huffman, et al.
The Journal of Clinical Endocrinology and Metabolism|May 5, 2005
Regulation of neuroendocrine differentiation in gastrointestinal carcinoid tumor cells by notch signalingEric K Nakakura, Virote R Sriuranpong, Muthusamy Kunnimalaiyaan, et al.
The Journal of Clinical Investigation|February 14, 1998
Activated Raf-1 causes growth arrest in human small cell lung cancer cellsR K Ravi, E Weber, M McMahon, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 1, 1985
Linkage map of the short arm of human chromosome 11: location of the genes for catalase, calcitonin, and insulin-like growth factor IIS D Kittur, J W Hoppener, S E Antonarakis, et al.
Carcinogenesis|June 1, 1989
Computational analysis of structural and energetic consequences of DNA methylationF H Hausheer, S N Rao, M P Gamcsik, et al.
Gene|June 16, 2000
Cloning and chromosomal localization of the human BARX2 homeobox protein geneA Krasner, L Wallace, A Thiagalingam, et al.
British Journal of Cancer|October 1, 2014
A phase I trial of vertical inhibition of IGF signalling using cixutumumab, an anti-IGF-1R antibody, and selumetinib, an MEK 1/2 inhibitor, in advanced solid tumoursB A Wilky, M A Rudek, S Ahmed, et al.
Clinical and Translational Science|August 2, 2020
A Phase I Study of Dinaciclib in Combination With MK-2206 in Patients With Advanced Pancreatic CancerAdrian G Murphy, Marianna Zahurak, Mirat Shah, et al.
Cancer Biology & Therapy|July 20, 2011
Cyclin-dependent kinase inhibitor Dinaciclib (SCH727965) inhibits pancreatic cancer growth and progression in murine xenograft modelsGeorg Feldmann, Anjali Mishra, Savita Bisht, et al.
Pageof 15

Showing results (131-140 of 150) with videos related to

Sort By:
Pageof 15
Cancer Research|October 5, 2001
BARX2 induces cadherin 6 expression and is a functional suppressor of ovarian cancer progressionG C Sellar, L Li, K P Watt, et al.
Atmosphere|July 18, 2018
The Global Precipitation Climatology Project (GPCP) Monthly Analysis (New Version 2.3) and a Review of 2017 Global PrecipitationR F Adler, M Sapiano, G J Huffman, et al.
The Journal of Clinical Endocrinology and Metabolism|May 5, 2005
Regulation of neuroendocrine differentiation in gastrointestinal carcinoid tumor cells by notch signalingEric K Nakakura, Virote R Sriuranpong, Muthusamy Kunnimalaiyaan, et al.
The Journal of Clinical Investigation|February 14, 1998
Activated Raf-1 causes growth arrest in human small cell lung cancer cellsR K Ravi, E Weber, M McMahon, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 1, 1985
Linkage map of the short arm of human chromosome 11: location of the genes for catalase, calcitonin, and insulin-like growth factor IIS D Kittur, J W Hoppener, S E Antonarakis, et al.
Carcinogenesis|June 1, 1989
Computational analysis of structural and energetic consequences of DNA methylationF H Hausheer, S N Rao, M P Gamcsik, et al.
Gene|June 16, 2000
Cloning and chromosomal localization of the human BARX2 homeobox protein geneA Krasner, L Wallace, A Thiagalingam, et al.
British Journal of Cancer|October 1, 2014
A phase I trial of vertical inhibition of IGF signalling using cixutumumab, an anti-IGF-1R antibody, and selumetinib, an MEK 1/2 inhibitor, in advanced solid tumoursB A Wilky, M A Rudek, S Ahmed, et al.
Clinical and Translational Science|August 2, 2020
A Phase I Study of Dinaciclib in Combination With MK-2206 in Patients With Advanced Pancreatic CancerAdrian G Murphy, Marianna Zahurak, Mirat Shah, et al.
Cancer Biology & Therapy|July 20, 2011
Cyclin-dependent kinase inhibitor Dinaciclib (SCH727965) inhibits pancreatic cancer growth and progression in murine xenograft modelsGeorg Feldmann, Anjali Mishra, Savita Bisht, et al.
Pageof 15